September 19, 2019 Foamix Announces Enrollment of First Patient in Phase 2 Acne Clinical Trial for FCD105 Minocycline 3% and Adapalene 0.3% Combination Foam View Article
September 16, 2019 Syqe Enters Into Distribution Agreement With TerrAscend to Bring Revolutionary Medical Cannabis Treatment to Canada View Article
Syqe Enters Into Distribution Agreement With TerrAscend to Bring Revolutionary Medical Cannabis Treatment to Canada
September 4, 2019 Alpha Tau Medical Appoints Jefferson University Radiation Oncologist Robert Den as Chief Medical Officer View Article
